US Patent 9340582 Bioconjugates of synthetic apelin polypeptides
Patent 9340582 was granted and assigned to Novartis on May, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+118 characters)
Article
Patent abstract
The invention provides a bioconjugates comprising a synthetic polypeptide of Formula I′ (SEQ ID NO: 1):
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Changgang Lou0
Eric Peters0
Frederic Zecri0
Hongjuan Zhao0
Jun Yuan0
Philipp Grosche0
Shari Lynn Caplan0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09340582 Bioconjugates of synthetic apelin polypeptides US Patent 9340582 Bioconjugates of synthetic apelin polypeptides
Infobox
Patent Number
093405820
Patent Number
93405820
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
093405820
Date of Patent
May 17, 2016
0Patent Application Number
143362900
Date Filed
July 21, 2014
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09340582 Bioconjugates of synthetic apelin polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09340582
Date of patent
May 17, 2016
Patent application number
14336290
Date Filed
July 21, 2014
Patent primary examiner
Find more entities like US Patent 9340582 Bioconjugates of synthetic apelin polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
